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Abstract
The lithium-pilocarpine model of epilepsy reproduces in rodents several features of human temporal lobe epilepsy, by
inducing an acute status epilepticus (SE) followed by a latency period. It has been proposed that the neuronal network
reorganization that occurs during latency determines the subsequent appearance of spontaneous recurrent seizures. The
aim of this study was to evaluate neuronal and glial responses during the latency period that follows SE. Given the potential
role of astrocytes in the post-SE network reorganization, through the secretion of synaptogenic molecules such as
thrombospondins, we also studied the effect of treatment with the a2d1 thrombospondin receptor antagonist gabapentin.
Adult male Wistar rats received 3 mEq/kg LiCl, and 20 h later 30 mg/kg pilocarpine. Once SE was achieved, seizures were
stopped with 20 mg/kg diazepam. Animals then received 400 mg/kg/day gabapentin or saline for either 4 or 14 days. In
vitro experiments were performed in dissociated mixed hippocampal cell culture exposed to glutamate, and subsequently
treated with gabapentin or vehicle. During the latency period, the hippocampus and pyriform cortex of SE-animals
presented a profuse reactive astrogliosis, with increased GFAP and nestin expression. Gliosis intensity was dependent on the
Racine stage attained by the animals and peaked 15 days after SE. Microglia was also reactive after SE, and followed the
same pattern. Neuronal degeneration was present in SE-animals, and also depended on the Racine stage and the SE
duration. Polysialic-acid NCAM (PSA-NCAM) expression was increased in hippocampal CA-1 and dentate gyrus of SE-animals.
Gabapentin treatment was able to reduce reactive gliosis, decrease neuronal loss and normalize PSA-NCAM staining in
hippocampal CA-1. In vitro, gabapentin treatment partially prevented the dendritic loss and reactive gliosis caused by
glutamate excitotoxicity. Our results show that gabapentin treatment during the latency period after SE protects neurons
and normalizes PSA-NCAM probably by direct interaction with neurons and glia.
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Introduction
Epilepsy, a disorder characterized by recurrent seizures, is the
second most common neurological disorder, affecting more than
50 million people worldwide [1]. Animal models of epilepsy and
studies on human tissue from epileptic patients have shown that
epileptogenesis involves a number of cellular and molecular events
including alterations in brain circuitry, changes in gene expression,
neurochemical alterations in receptors and neurotransmitters,
aberrant neurogenesis and extended neuronal death [2;3].
Currently available pharmacological treatments are not disease-
modifying and only suppress seizures, therefore being anti-
epileptic but not anti-epileptogenic [4].
Recent experimental and clinical evidence has shown that the
activation of innate immunity and inflammatory pathways
contributes to the development of epilepsy [5;6]. It is also known
that microglial and astroglial cells are the main effectors of the
innate immune system in the brain. Activation of innate immunity
can be achieved by molecular patterns derived from pathogens
(Pathogen Associated Molecular Patters, PAMPs), and also by the
release of endogenous intracellular molecules induced by tissue
damage or cellular stress. Molecules of the latter kind are
collectively known as Damage Associated Molecular Pattern
(DAMP), and they efficiently activate pattern recognition receptors
(PRR) of different families, including toll-like (TLR) and the
Receptor for Advanced Glycation End products (RAGE).
Astrocytes play a major role in the regulation of the
inflammatory response in different human Central Nervous
System diseases, including epilepsy. Astrocytes and microglia
respond to neuronal alterations and brain damage with a generic
response of reactive gliosis, that involves secretion of proinflam-
matory cytokines and chemokines [7]. Several lines of evidence
show that epilepsy is related to inflammation and increased levels
of cytokines. In fact, virtually all the proinflammatory cytokines
are elevated in the cerebrospinal fluid and brain tissue of epileptic
patients (reviewed in [8]). A number of studies performed on
epileptic subjects have shown that cytokine level correlates with
the intensity and duration of epileptic seizures [9,10]. Reactive
gliosis is also associated with secondary epilepsy after traumatic or
ischemic brain injury, as well as with major epilepsy related
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pathologies such as hippocampal sclerosis and focal malformations
of cortical development [11]. Experimental models have provided
additional evidences of the astroglial participation in epileptogen-
esis. Reactive gliosis was a common finding after different
experimental paradigms of epilepsy [12;13;14]. However, the loss
of astrocytes after severe epileptic seizures was also found
[15;16;17], a fact that suggest that astrocytic malfunctioning could
also induce secondary neuronal loss [18]. Microglia and brain
resident dendritic cells also become activated in experimental
models of epilepsy [19].
Regarding the study of the specific signaling pathways involved,
the activation of NF-kB transcription factor regulates the
expression of several molecules that control inflammation and
cell survival. Induction of NF-kB-dependent transcription is a
common response after the activation of IL1R1/TLR pathways,
and has a major role in the control of innate immunity responses,
as it governs the expression of genes encoding downstream
mediators of inflammation, including IL-6, TNF-a, cyclooxygen-
ase-2 (Cox-2), or CCL2 (i.e., monocyte chemotactic protein-1)
(reviewed in [11]). Evidence from epileptic human tissue has
pointed out to the probable activation of the NF-kB pathway in
glia [20;21].
As regards pharmacological strategies, gabapentin was origi-
nally developed as an anticonvulsant drug that may act as a
GABA-analog, but recent studies have shown that it is able to
block the interaction of glial-derived thrombospondin 1–2 (TSP1–
2) with the a2d1 receptors that regulate excitatory synapses
formation [22;23]. On the other hand, gabapentin was demon-
strated to be an efficient drug for the control of neuropathic pain
[24]. It has been recently shown that its effect may be related to
the expression of a2d1 receptors in the glial cell population and
suppression of microglial reactive response [24].
In experimental models of TLE, the silent period between the
primary injury induced by SE and the onset of spontaneous
epileptic seizures, usually 21–30 days in the lithium pilocarpine
model of epilepsy, comprises several molecular and cellular
processes that are still obscure. Using the lithium-pilocarpine
model, our aim was to study this early period of the epileptogenesis
and to assess whether gabapentin is able to disrupt the early
astroglial and microglial response to SE.
Materials and Methods
Ethics Statement
All procedures involving animals and their care were conducted
in accordance with our institutional guidelines, which comply with
the NIH guidelines for the Care and Use of Laboratory Animals
and the principles presented in the Guidelines for the Use of
Animals in Neuroscience Research by the Society for Neurosci-
ence, and were approved by the CICUAL committee of the
School of Medicine, University of Buenos Aires (Res. Nr. 1278/
2012). All efforts were made to minimize animal suffering and to
reduce the number of animal used.
Materials
Primary Antibodies were purchased from Dako (anti-Glial
Fibrillary Acidic Protein, GFAP); Millipore-Chemicon (anti-
NeuN, anti-PSA-NCAM, anti-MAP2); Santa Cruz (anti-NF-kB
p65NLS) and Hybridoma Bank of the Iowa University (anti-
Nestin). Secondary fluorescent antibodies were from Jackson
Immunoresearch. Tomato-Lectin FITC, Fluoro Jade B, biotini-
lated secondary antibodies, extravidin complex, glutamate and
other chemicals were obtained from Sigma (St. Louis, MO).
Gabapentin (Neurontin) was from Pfizer (Argentina). DMEM,
antibiotics and glutamine were purchased from Invitrogen
(Carlsbad, CA); fetal calf serum was obtained from Natocor
(Cordoba, Argentina).
Animal Procedures
Adult male Wistar rats (200–250 gr) from the animal breeding
facility of the School of Pharmacy and Biochemistry (University of
Buenos Aires) were used in this study. Animals were housed under
controlled temperature, humidity and lighting conditions (20–
25uC, 60% humidity, 12 h/12 h light/dark cycle) with standard
laboratory rat food and water ad libitum, under the permanent
supervision of a professional technician. Rats were subjected to the
lithium-pilocarpine model of Temporal Lobe Epilepsy (TLE)
(reviewed in [25]). Animals were randomly divided into three
experimental groups. Two groups were injected with 3 mEq/kg
lithium chloride (LiCl) intraperitoneally (i.p.); the control group
received an equivalent volume of saline. Twenty hours later
animals received either saline i.p. or 30 mg/kg pilocarpine (Li-pilo
group). Animals that received saline-saline (control group) or Li-
saline did not show significant differences either in behavioral or
morphometric parameters, so to simplify images and graphs, only
Li-saline controls are shown. Behavioral seizures were evaluated
according to the Racine scale [26]. Status Epilepticus (SE) was
defined as continuous seizures with a Racine score of 3 to 5,
without returning to lower stages for at least 5 minutes.
Pilocarpine-treated animals were divided into two groups (SE
and No SE) depending on their behavioral response, as described
below in the ‘‘Results’’ section. Approximately 70% of the
pilocarpine treated rats showed acute behavioral features of SE
(SE group) between 40–60 minutes after pilocarpine injection.
Thirty percent of the animals that were injected with pilocarpine
did not develop SE, showing only behavioral signs corresponding
to stages 1–2 of the Racine score and were considered as a
separate experimental group (No SE). All animals received
20 mg/kg diazepam 15 or 30 minutes after the onset of SE and
doses were repeated as needed to terminate seizures. SE duration
was limited to 30 min to reduce animal mortality, considering that
it was described that 15–30 min are enough for establishing a
chronic period of spontaneous seizures [25]. To study cell
morphology, different time points were established: 3, 7, 15 or
21 days post-SE (DPSE). At those time points, animals were
deeply anaesthetized with ketamine/xylazine (90/10 mg/kg, i.p.)
and were perfused through the left ventricle as described [27].
Then, brains were cryoprotected, snap frozen and coronal 25–
50 mm thick brain sections were cut using a cryostat. Free floating
sections were kept in a cryoprotective solution (30% glycerol, 20%
ethylene glycol in 0.05 M phosphate buffer) at 220uC until use.
To study the effect of gabapentin, two treatment protocols were
started 24 h after the onset of the epileptic seizures. For that
purpose separate groups of animals from all experimental
conditions (control, control-Li, Li-pilo No SE, Li-pilo SE) received
daily gabapentin injections (400 mg/kg/day i.p) for either 4 or
14 days, or an equal volume of saline (Figure 1). Brain sections
were obtained as described above.
Immunohistochemistry
Brain sections of animals from all experimental groups were
simultaneously processed in the free floating state as previously
described [27]. After endogenous peroxidase activity inhibition,
brain sections were permeabilized with 1% Triton X-100 in PBS,
unspecific binding blocked with normal goat serum (3%) and
sections incubated with the respective primary antibody. All
antibodies were diluted in a solution with phosphate-buffered
saline (PBS), 1% Triton X-100 and 3% normal goat serum. After
Gabapentin Effects on a Model of Epilepsy
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48 h incubation at 4uC, slices were rinsed and incubated with
biotinylated secondary antibodies and extravidin complex. Devel-
opment of peroxidase activity was carried out with 0.035% w/v
3,39 diaminobenzidine plus 2.5% w/v nickel ammonium sulfate
and 0.1% v/v H2O2 dissolved in acetate buffer 0.1 M pH 6.0.
Controls for the immunohistochemistry procedure were routinely
performed by omitting the primary antibody. These control
sections did not develop any immunohistochemical labeling.
Photographs were taken with a Zeiss Axiophot microscope (Carl
Zeiss, Oberkochen, Germany) equipped with an Olympus Q-
Color 5 camera. For double immunofluorescence studies, blockage
of unspecific binding was performed with 10% normal goat serum.
Primary antibodies were used at the following dilutions: anti-
GFAP (1:1000), anti-nestin (1:800), anti-NeuN (1:1000), anti-
PSANCAM (1:1000), anti-P65NLS (1:800). Fluorescent secondary
antibodies conjugated with FITC or Rhodamine RRX were used
at 1:800 dilution, and nuclear counterstaining was done with
Hoechst 33342 (2 mg/ml). Immunofluorescence images were
taken in an Olympus IX-81 microscope equipped with a DP71
camera (Olympus, Tokyo, Japan).
Fluoro Jade B Staining
Neuronal degeneration was assessed by Fluoro Jade B staining
according to the Schmued and Hopkins protocol [28]. In brief,
brain sections were mounted on coated slides and immersed in a
solution with 1% sodium hydroxide in 80% ethanol for 5 minutes.
Slides were then immersed 2 minutes in 70% ethanol and 2
minutes in distilled water. After that, sections were exposed to a
solution of 0.06% potassium permanganate for 10 min and rinsed
in distilled water for 2 min. Brain sections were exposed during
20 min to a staining solution of 0.0004% Fluoro Jade B (Sigma) in
0.09% acetic acid. After rinsing for 1 min in distilled water, slides
were dried at 50uC for 15 min, cleared in xylene and cover
slipped.
Dissociated Mixed Cell Culture from Postnatal Rat
Hippocampus
This procedure was performed according to Lee and Parpura
[29] with minor modifications. Hippocampi were obtained after
brain dissection of deeply anaesthetized 3 days old Wistar rats and
incubated for 1 h with papain (20 U/ml) at 37uC in 5% CO2.
Papain was removed and tissue was washed once in DMEM.
Hippocampi were mechanically dissociated with a fire-polished
glass serological pipette until no visible clamps remained. Cells
were plated onto poly-L-lysine-coated multiwell chambers and fed
with DMEM, 1% glutamine, 1% penicillin-streptomycin and 10%
fetal calf serum. Cultures were maintained at 37uC in a humidified
atmosphere with 5% CO2; 50% of the medium was replaced by
fresh medium every 3 days. This protocol was kindly provided by
Dr. Vladimir Parpura (UAB, USA). Excitotoxic glutamate
exposure was performed by incubating during 30 min mixed
hippocampal neuroglial cultures with 500 mM glutamate. Then,
medium was replaced by fresh medium including gabapentin at 5,
25, 50 or 100 mg/ml. For immunocytochemistry, cultures were
washed with PBS and fixed with 4% paraformaldehyde plus 4%
sucrose in PBS, pH 7.2 for 15 min at 18–25uC. Cells were then
washed three times with cold PBS and permeabilized with 0.1%
Triton X-100. The procedure was then followed as stated for tissue
sections.
Quantitative Studies
Morphometrical studies to analyze cell morphology and area
fraction occupied by stained cells were performed using the NIH
ImageJ software. Images taken with the microscope were captured
with a digital camera, transformed to 8-bits gray scale, normalized,
and an interactive threshold selection was carried out. Once the
threshold was determined, it was kept fixed for the entire
experiment. Following threshold selection, identification of the
structures was performed using the software and indicating the
maximal and minimal size of the expected structures (cells). Images
of partial cells were excluded from the counting processes. Area
fraction covered by immunostained cells was obtained with the
ImageJ software. Experiments were repeated 3 times with similar
results; a representative experiment is shown in the figures. A
minimum of 4–5 animals per condition was used in each
experiment. Statistical analysis was performed by one-way
ANOVA and Student–Newman–Keuls post test. Significance
was set at p,0.05 using Graph Pad Software (GraphPad Software
Inc., San Diego, CA, USA). Data were presented as mean 6
SEM.
Results
Reactive Gliosis Correlates with the Racine Scale Score
Reached by the Animals
The progressive development of epileptic seizures was behav-
iorally monitored after lithium-pilocarpine treatment, and had its
onset 40–60 min after pilocarpine injection. Seizures duration was
limited to 15 or 30 min by diazepam administration. Rats treated
only with lithium (control Li) did not develop behavioral changes.
Animals that developed seizures were classified according to the
Racine scale [26]. Early stages 1 and 2 were mostly associated with
facial and oral activity. In stage 3, seizures recruited more distant
structures, and forelimb clonus started. In stage 4, seizures were
generalized and showed stronger clonus and rearing, and then
Figure 1. Schematic representation of the in vivo and in vitro
paradigms used in this study. A: In vivo lithium-pilocarpine
exposure to describe neuro-glial alterations induced by the experimen-
tal model. B: Gabapentin treatment preformed on animals exposed to
the lithium-pilocarpine experimental model. C: In vitro paradigm to
study gabapentin effects on dissociated mixed cell culture from
postnatal rat hippocampi. Li: Lithium chloride; pilo: pilocarpine; Gp:
gabapentin; SE: status epilepticus. See material and methods for details.
doi:10.1371/journal.pone.0078516.g001
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dramatic rearing-and-falling (full stage-5 pattern), as previously
described [28]. In our population, an average of 30% of the
pilocarpine-injected animals showed stages 1 or 2; 50–70% of the
animals showed responses ranging from stage 3 to 5, and 10% of
animals died in the 3–4 days following SE. In all cases, seizures
were stopped after 15 or 30 min of SE with diazepam. The
animals included in the SE group were those that presented
continuous seizures fluctuating from stage 3 to 5 of the Racine
scale. Animals with scores of 1 or 2 were considered as a separate
experimental group (No SE).
Brain sections of the animals that presented seizures showed a
profuse reactive gliosis, demonstrated by increased GFAP and
nestin immunostaining. GFAP-positive astrocytes showed enlarged
soma size and longer projections, together with increased GFAP
expression. Figure 2A shows that reactive gliosis intensity in
hippocampus and pyriform cortex correlated with the Racine
stage reached by the animals. While animals at stages 1–2 showed
only a minor hypertrophy, animals at stages 3–5 presented the
maximal reactive gliosis by 7 days post-SE (Figure 2A). Whole
brain images showed that reactive gliosis is very diffuse, affects the
entire brain from 7DPSE to 21DPSE (Figure 1B) and dramatically
alters astroglial cell morphology (Figure 2C). To further study the
reactive gliosis pattern and to quantify the intensity, we analyzed
the area occupied by GFAP immunoreactive astrocytes at different
time points after the induction of epileptic seizures. An increased
area fraction of GFAP-positive astrocytes was detected 7 and
15 DPSE in the hippocampal CA-1 area and pyriform cortex
respectively (Figure 1C; 1D).
Nestin is expressed by undifferentiated astrocytes; when found
in adult animals beyond the neuro- and gliogenic niches, it is
usually related to exacerbated reactive gliosis, a phenomenon that
induces astrocyte de-differentiation. Nestin expression was found
after pilocarpine-induced SE in the pyriform cortex of animals that
reached Racine stages 3–5 (Figure 3A). The peak of maximal
nestin expression was detected 15 DPSE (Figure 3B). Interestingly,
this peak correlated with the reduction of MAP-2 expression in
neurons of certain areas of the pyriform cortex (Figure 3C).
Microglial cells also responded to the cellular stress induced by
SE. As shown in figure 4A, reactive microglial cells identified by
tomato lectin were present from 3 DPSE up to 21 DPSE.
However, microglial abundance and morphology strongly
changed after SE (Figure 4A, 4B). Maximal microglial reactivity
peaked around 15 DPSE and was still significantly reactive
21 DPL (Figure 4B). Furthermore, NF-kB subunit p65 identified
by the exposure of the p65NLS, colocalized with reactive
microglia by 3DPSE (Figure 4A).
SE-induced Neuronal Degeneration
Neuronal degeneration is a well-known effect of SE induced by
different experimental paradigms. In our study, the Racine stage
reached by the animals correlated with the number of hippocam-
pal neurons showing morphological signs of degeneration and
positive fluoro Jade B staining by 7DPSE (Figure 5A). On the
other hand, extending the duration of the SE dramatically
increased the number of degenerating neurons, an effect that
was still evident 14 DPSE (Figure 5B).
After 30 min of SE, neuronal degeneration could also be
demonstrated by mobilization of neuronal nuclear protein NeuN
from its typical nuclear localization to the cytoplasm, or even its
disappearance from the neuronal soma (Figure 6A). In agreement
Figure 2. Reactive gliosis after lithium-pilocarpine induced SE. A: Astroglial hypertrophy correlates with the Racine stage reached by the
animals. GFAP immunostaining showing the astroglial hypertrophy (i.e. increased soma size, larger projections and increased GFAP expression) by
7 days days after pilocarpine treatment. Control images belong to the group of lithium-saline treated rats. Bar = 70 mm. B: Low magnification images
showing the reactive gliosis in the entire brain that progresses in the days following SE. Note the reduction in GFAP expression in the layer II of
pyriform cortex that is recovered by 21DPSE. C: Higher magnification pictures of GFAP-positive astrocytes in the hippocampal CA-1 area and layer I of
pyriform cortex. Bar = 70 mm. D: Quantitative study showing the area fraction percent occupied by GFAP-positive astrocytes in hippocampal CA-1 (D)
and layers I and III of pyriform cortex (E) at different number of days post-status epilepticus (DPSE). Duration of SE: 30 min. Data on the graphs are
shown as means 6 SEM; significance vs. control group was represented as indicated: *p,0.05; **p,0.01; ***p,0.001 after ANOVA and Student
Newman Keuls post-test.
doi:10.1371/journal.pone.0078516.g002
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with the previous result with FJB staining, the progressive loss of
NeuN staining from 7 DPSE up to 21 DPSE (Figure 6B) evidences
that neuronal degeneration is a process that progresses during the
latency period after SE.
Figure 3. Reactive astrocytes in animals that reached SE express the immature glial marker nestin. A: Low magnification images
showing the induction of nestin in the brain of animals that reached SE (Racine 3–5) but not in the animals that did not achieve SE (Racine 1–2). Note
the increased nestin expression in the layer II of pyriform cortex (where GFAP was reduced in Fig. 2B). B: Quantitative study showing the area fraction
percent occupied by nestin-positive cells, that peaked by 15 days post-SE (DPSE). Data on the graphs are shown as means 6 SEM; *p,0.05;
**p,0.01; ***p,0.001 after ANOVA and Student Newman Keuls post-test. C: Images showing the increased nestin expression in the pyriform cortex
layer 2, where MAP-2 neuronal dendrites marker was lost after SE. The inset shows that nestin-positive cells have a typical glial morphology.
Bar = 90 mm. The duration of the SE was 30 min.
doi:10.1371/journal.pone.0078516.g003
Gabapentin Effects on a Model of Epilepsy
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Gabapentin Treatment Improved Neuronal Survival and
Reduced Reactive Gliosis after SE
Gabapentin was originally developed as a gabaergic agonist, but
subsequent studies have shown that it blocks a2d1 neuronal
receptors; reducing the synaptogenesis induced by glial-derived
thrombospondin [22]. More recently it has been shown that
gabapentin is also able to reduce microglial reactivity in models of
hyperalgesia [24]. We therefore asked whether gabapentin would
be able to reduce the neuronal and glial alterations induced by the
Figure 4. Reactive microglia is present in animals that reached SE. A: Images show the tomato-lectin positive cells in the pyriform cortex and
the increased immunoreactivity for p65 NF-kB subunit exposing the nuclear localization signal (NLS). Note that reactive microglia increases during
the period following SE, while p65NLS increases between 3DPSE and 7DPSE. Bar = 40 mm. B=Quantitative study showing the area fraction percent
occupied by tomato-lectin positive microglia, that peaked by 15 days post-SE (DPSE). The duration of the SE was 30 min. Data on the graphs are
shown as means 6 SEM; significance vs. control group is represented as: *p,0.05; **p,0.01; ***p,0.001; while significance vs. 7 and 21DPSE is
represented as: aa p,0.01, after ANOVA and Student Newman Keuls post-test.
doi:10.1371/journal.pone.0078516.g004
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SE. For this purpose, a group of animals that had achieved SE
(Racine score .3) was daily treated with gabapentin 400 mg/kg
for different periods of time (4 or 14 days after SE). Gabapentin
treatment did not induce significant changes in animal survival
rates to SE; however, animals treated with the drug recovered
weight faster (data not shown). The 14-day gabapentin treatment
partially reduced SE-induced neurodegeneration, as evidenced by
loss of NeuN staining in hippocampal CA-1 pyramidal cell layer
and pyriform cortex (Figure 6A). The gabapentin protective effect
was even evident in the short 4-day treatment, as it partially
protected pyriform cortex neurons from SE-induced degeneration
(Figure 6B). The results of the 4-day treatment were still evident
21 DPSE, showing the long lasting effects of the short treatment
(Figure 6B).
The neuroplasticity marker PSA-NCAM is expressed in normal
brains in areas showing high rate of remodelling and neuronal
plasticity. As shown in Figure 6C, PSA-NCAM is increased in
hippocampal CA-1 after SE. Only the long 14-day gabapentin
treatment was able to abolish the SE-induced PSA-NCAM
increase in hippocampal CA-1 and CA2/3; however, this
treatment was unable to affect PSA-NCAM expression in dentate
gyrus (Figure 6C).
SE-induced reactive gliosis was also reduced by the 4-day
gabapentin treatment, as shown by a reduction in the area
immunostained for GFAP astroglial marker (Figure 7A), essentially
due to the reduced number of astrocytes with shorter projections
and smaller soma size (Figure 7B). In concordance with the
reduced reactive gliosis induced by gabapentin treatment, the area
fraction occupied by nestin expressing cells was reduced by
21 DPSE (Figure 7C).
Microglial cell reactivity was also reduced by the short
gabapentin treatment. Figure 7D and 7E show the dramatic
Figure 5. Degenerating neurons after SE. A: Degenerating neurons indentified by Fluoro-JB staining appeared in the hippocampus of animals
that reached SE (Racine scale 3–5). Control images belong to the group of lithium-saline treated rats. Bar = 40 mm. B: Increasing the duration of SE
from 15 min to 45 min increases the number of degenerating neurons in the pyriform cortex, striatum and hippocampus. Bar = 60 mm.
doi:10.1371/journal.pone.0078516.g005
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reduction in tomato lectin-positive microglial cells by 21 DPSE in
gabapentin-treated animals.
Gabapentin Protects Neurons and Reduces Reactive
Gliosis after Glutamate-induced Excitotoxicity in vitro
After evidencing the protective effect of in vivo gabapentin
treatment, we wondered whether this drug could directly protect
primary neurons from the excitotoxicity induced by a glutamate
pulse. In order to test the hypothesis, derived from the previous
results, of a glial participation in the gabapentin-induced effects,
we used dissociated mixed cell culture from postnatal rat
hippocampi. This culture contains most hippocampal cell types,
including glial cells and neurons, and shows both the chemical and
physical neuroglial interaction. To mimic the initial excitotoxic
stress induced by SE, we exposed the culture to a 500 mM
glutamate pulse of 30 min. Twenty four hours after the glutamate
pulse; there was a reduction in the number and complexity of
neuronal projections (Figure 8A, 8B). Neurons showed dendrite
retraction without significant neuronal death, as assessed by
nuclear morphology (data not shown), probably due to the
presence of astrocytes that regulate extracellular levels of
glutamate by uptake. Astroglial response to the glutamate pulse
involved an increase in stellate astrocytes abundance (Figure 8C).
This typical stellation phenomenon is considered as the in vitro
correlation of the reactive gliosis observed in vivo [30].
The dose response gabapentin treatment showed that 50 mg/ml
was the most effective to prevent the reduction in neurites number
and complexity induced by the glutamate excitotoxic pulse
(Figure 8B). The effect of gabapentin on control neurons not
exposed to excitotoxic glutamate showed a trend to be detrimen-
tal, but it did not reached statistical significance (Figure 8B).
Gabapentin exposure was also able to reduce astroglial stellation
when used at the lowest dose tested (5 mg/ml) and was ineffective
at 25 and 50 mg/ml (Figure 8C). The largest gabapentin dose used
(100 mg/ml) presented a detrimental toxic effect both on control
or glutamate-exposed dissociated mixed cell hippocampal culture
(not shown).
Figure 6. Gabapentin (Gp) treatment reduces neuronal degeneration and exacerbated plasticity induced by SE. A: Images show the
loss of NeuN immunostaining and the disorganization of the CA-1 hippocampal pyramidal cell layer after 30 min of SE and the effect of 14 days
treatment with daily doses of Gp. Note the partial preservation of NeuN staining in the Gp-treated animals. Control images were obtained from
lithium-saline group, whereas images from Gp group were obtained from lithium-saline treated with gabapentin. Bar = 14 mm. B: The short 4-day
treatment with Gp also reduced neuronal degeneration with loss of NeuN staining by 21 days post-SE (21DPSE) in the pyriform cortex. Bar = 40 mm.
C: Images show the increased PSA-NCAM expression in the hippocampal CA-1 pyramidal cell layer and the dentate gyrus (DG). Only the 14-day Gp
treatment was able to abolish the SE-induced PSA-NCAM expression in the CA-1 but not in the DG. Bar = 200 mm.
doi:10.1371/journal.pone.0078516.g006
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Figure 7. Gabapentin (Gp) treatment reduced reactive gliosis in the animals subjected to SE. A: Quantitative study showing the area
fraction percent occupied by GFAP positive astrocytes in the pyriform cortex and the reduction in the area induced by the 4-day Gp treatment. B:
Images show the reduction in the GFAP-positive astrocytes in the hippocampus induced by the 4-days Gp treatment. Bar = 50 mm. C: Quantitative
study showing the area fraction percent occupied by nestin positive astrocytes in the pyriform cortex and the reduction in the area induced by the 4-
day Gp treatment. D: Tomato-lectin positive microglia was also reduced by the 4-day Gp treatment. E: Images show the tomato-lectin positive
microglial cells in the pyriform cortex, bar = 20 mm. The duration of the SE was limited to 30 min. Data on the graphs are shown as means 6 SEM;
significance is shown vs. control group unless indicated: *p,0.05; **p,0.01; ***p,0.001 after ANOVA and Student Newman Keuls post-test.
doi:10.1371/journal.pone.0078516.g007
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Figure 8. Gabapentin protects primary hippocampal neurons and reduces astroglial stellation induced by glutamate exposure. A:
Representative images of neurons immunostained with MAP-2 identified in dissociated mixed cell culture from postnatal rat hippocampi exposed to
glutamate and treated with gabapentin at the indicated doses for 24 h. Bar = 15 mm. B: Quantitative study showing the mean number of MAP-2
immunoreactive dendrites in hippocampal neurons in the control and glutamate-exposed group; note the prevention in the loss of projections
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Discussion
Clinical data and experimental evidence indicate that epilepto-
genesis is a multifactorial process that comprises an initial event,
usually accompanied by acute seizure activity, followed by a silent
period without seizure activity. After this highly variable silent
period, spontaneous seizures appear; they grow in frequency and,
in some cases, become refractory to treatment (see for review [4]).
A plethora of molecular events seems to occur during this period,
but accumulating evidence shows that glial conversion to the
proinflammatory reactive phenotype and the activation of PRR,
mainly toll-like receptors, has a major role in the exacerbated
neuronal irritability. Reactive glia is also probably linked to an
expansion of neuronal death [31] and an altered synaptic
reconnection, as it causes the release of synaptogenic molecules
like TSP1–2 and hevin, which may generate spurious synapses
[32]. In fact, hevin was demonstrated to be localized in excitatory
synapses after pilocarpine-induced seizures [33].
In agreement with a determinant role of glial cells in the latency
period following seizures, we here demonstrate that reactive gliosis
initiates early after the initial SE (7 days) and reaches a peak
around 15 DPSE. Astrocytes become reactive, with increased
projection length and enlarged soma size both in hippocampus
and pyriform cortex. Moreover, nestin, a marker of undifferen-
tiated glial cell precursors appeared in hippocampus and pyriform
cortex of animals that reached stages 3–5 of the Racine scale. The
appearance of undifferentiated cells markers is usually a sign of
reactive gliosis reaching the stage of severe diffuse reactive gliosis,
with increased cell division and long-lasting reorganization of
tissue architecture [34]. It is interesting to note that only animals
that reached SE (continuous seizures with a Racine score of 3–5)
presented nestin immunostaining and maximal astroglial hyper-
trophy detected with GFAP. These animals also showed partial
loss of GFAP staining in pyriform cortex, which was replaced by
nestin-positive fibrillar cells, supporting the idea of a de-
differentiation of astrocytes. These de-differentiated astrocytes
expressing nestin are likely to be an important source of
synaptogenic molecules that may be involved in the spurious
synaptogenesis proposed as the molecular basis of epileptogenesis.
Microglial cells also became reactive after SE. Reactive
microglia, evaluated by the binding of tomato lectin, was present
3 DPSE, and maximal reactivity was evidenced 15 DPSE, then
persisting during all the observation period (21 days). Interestingly,
a significant number of microglial cells showing a reactive state
also presented nuclear localization of the NF-kB p65 subunit
exposing the p65NLS. This fact indicates that the NF-kB pathway,
the generic output activated by DAMP/PRR signaling, is
probably active in these cells.
Neuronal degeneration was known to be induced by different
experimental paradigms of SE [35;36;37;38;39;40]. In our
experimental setting, the duration of SE correlated with the
detection of FJB+ degenerating cells in hippocampus, pyriform
cortex and striatum. After SE, a significant loss of NeuN and
MAP-2 staining was observed, which recovered during the days
following SE. The loss of NeuN nuclear staining and reduction in
MAP-2 positive dendrites are recognized parameters of neurode-
generation that may be to some extent reversible [27;41].
However, the concomitant appearance of FJB+ cells is probably
showing irreversible neuronal loss. This massive neuronal degen-
eration is a source of DAMP, which may bind to PRR in microglia
and astrocytes, the main effectors of innate immunity in the brain,
and activate them.
It has been demonstrated that gabapentin efficiently blocks
a2d1 neuronal receptor, reduces TSP-induced synaptogenesis [22]
and reduces epileptiform discharges in a model of post-traumatic
epilepsy [23]. Gabapentin was also shown to have analgesic
properties in a wide range of chronic pain models, and evidence
from experimental models has shown that this effect is probably
related to the gabapentin suppressive effect of microglial activation
[24;42]. Furthermore, the activation of the PAMP/PRR pathway
by the complete Freund adjuvant was able to induce the
expression of the proposed gabapentin receptor a2d1 in microglia
and astroglia [24].
In our experimental model, gabapentin treatment was able to
partially reduce the neuronal degeneration induced by SE. The
partial inhibition of neuronal degeneration was identified as
persistence of NeuN staining and reduction in FJB positive cells,
especially in hippocampus. In addition, gabapentin treatment
reduced the intensity of reactive gliosis, both in microglial and
astroglial cells. This result is in agreement with the reported effect
in experimental models of pain [24], and the partially protective
action on neurons is likely to be related to the reduction in the glial
conversion to the proinflammatory/neurodegenerative phenotype
[43].
Interestingly, gabapentin treatment induced a significant change
in the distribution of the synaptic plasticity marker PSA-NCAM.
After SE, animals showed increased PSA-NCAM staining in
hippocampal dentate gyrus and terminals arriving to the CA-1
pyramidal cell layer. A similar increase in PSA-NCAM immuno-
labeling was recently reported in pilocarpine-treated mice [44],
kainic-acid treated rodents [45;46] and animals exposed to the
amygdala kindling model of epilepsy [47]. It is believed that an
increased PSA-NCAM staining reflects the exacerbated plasticity
and remodeling induced in epileptic seizures that support the long-
lasting changes in neural excitability. Gabapentin treatment
slightly reduced the intensity of PSA-NCAM staining in DG and
abolished the SE-induced increase in PSA-NCAM expression in
hippocampal CA-1. It was described that gabapentin blocks the
a2d1 neuronal receptor, interfering with the binding of glial-
derived TSP1–2 and impeding the formation of new excitatory
synapses [22]. Gabapentin also reduces epileptiform discharges in
a model of post-traumatic epilepsy [23]. In this scenario, it is
reasonable to think that the gabapentin-induced changes in PSA-
NCAM expression are the morphological correlate of the drug’s
reported ability to block aberrant synaptogenesis that results from
post-SE exacerbated neural plasticity.
In the adult brain, deafferentiation results in an initial synaptic
loss, followed by a long-lasting reactive synaptogenesis where
afferent axons attempt to form new synaptic connections [48]. In a
model of trigeminal deafferentiation, Lo and colleages [48] have
demonstrated that reactive astrocytes are involved in the induction
of reactive synaptogenesis, and that blockage of astroglial
purinergic signaling or TSP effects abolished reactive synaptogen-
esis. Since gabapentin blocks TSP1–2 but also reduces reactive
gliosis, it is reasonable to speculate that gabapentin interferes with
the reactive synaptogenesis induced by SE.
induced by the 50 mg/ml gabapentin treatment. C: Quantitative study of the astroglial stellation in the control and glutamate exposed group; note
that a low dose of gabapentin prevents astroglial stellation induced by glutamate exposure. The inset presents typical images of astrocytes in the
dissociated mixed cell culture from postnatal rat hippocampi. Data on the graphs are shown as means6 SEM; significance is shown vs. control group
unless indicated: *p,0.05; **p,0.01; ***p,0.001 after ANOVA and Student Newman Keuls post-test.
doi:10.1371/journal.pone.0078516.g008
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The protective effect of gabapentin was also observed in
dissociated mixed neuroglial hippocampal cultures, where gaba-
pentin essentially protected neurons from glutamate-induced
neurite reduction, without significant effects in cultures not
exposed to glutamate. However, at 100 mg/ml gabapentin had
detrimental effects, probably due to its capacity to induce
alterations in calcium trafficking, as reported by several groups
[49;50;51;52;53]. Gabapentin also had effects on astrocytes where
5 mg/ml prevented glutamate-induced astroglial stellation. In
vitro, astroglial stellation is considered a correlate of the in vivo
reactive gliosis [30]. Again, 100 mg/ml gabapentin showed a
detrimental effect on astrocytes. From these results obtained in
dissociated mixed cell culture from postnatal rat hippocampi we
determined that gabapentin has a direct effect on glutamate-
exposed hippocampal neurons and astrocytes. Interestingly, the
gabapentin effects seem to be evident only in glutamate-exposed
cultures.
Taken together, our results indicate that gabapentin treatment
during the initial phase of the silent period that follows SE was able
to significantly improve different morphological parameters of
neuronal damage, including mobilization of NeuN and increased
PSA-NCAM expression in hippocampal fibers. In addition,
gabapentin also reduced reactive gliosis in astrocytes and
microglia. Based on the evidences showing that gabapentin blocks
the a2d1 receptors present both in neurons and glial cells, we
propose that gabapentin reduces SE-induced brain alterations by
synergistically acting on neurons, astrocytes and microglia.
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